Familial hypercholesterolaemia in patients with ischaemic stroke or transient ischaemic attack

Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins

(2016) Loukianos S. Rallidis et al.   ATHEROSCLEROSIS

Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia

(2016) Thomas Grenkowitz et al.   ATHEROSCLEROSIS

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

(2016) Marianne Benn et al.   EUROPEAN HEART JOURNAL

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

Predictive value of ABCD2 and ABCD3-I scores in TIA and minor stroke in the stroke unit setting

(2016) Michael Knoflach et al.   NEUROLOGY

Europe aspires to set the record straight on familial hypercholesterolaemia

(2015) Gerald F. Watts et al.   ATHEROSCLEROSIS

Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis

(2015) Fotios Barkas et al.   ATHEROSCLEROSIS

Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death

(2015) Henriette Walaas Krogh et al.   EUROPEAN HEART JOURNAL

Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes

(2015) David Nanchen et al.   EUROPEAN HEART JOURNAL

Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study

(2015) Johann Willeit et al.   LANCET NEUROLOGY

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

An Updated Definition of Stroke for the 21st Century

(2013) Ralph L. Sacco et al.   STROKE

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

(2012) Evan A Stein et al.   LANCET